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Editorial Comment
Acetylcholine and Coronary
Artery Spasm: Important Insight
or Squeeze Play?*
RICHARD O . CANNON III . MD, FACC
Berlesda. M,u,1 d
For over 100 years, ergot alkaloids have been known to be
powerful vasoconstrictor agents, even capable of causing
gangrene (1). In the late 1940s, intravenous administration of
ergotamine to patients with "organic heart disease" s
found to cause electrocardiographic (ECG) changes and
chest pain, believed to represent a direct vasoconstrictor
effect of ergotamine on the coronary arteries, Stein and
Weinstein (2) reported the responses of 30 patients. 15 of
whom had a clinical diagnosis of coronary artery disease, to
ergonovine, 0.5 to 0.6 mg in incremental doses . In 6 of these
15 patients, prior exercise testing had failed to produce ST
segment depression. In all 15
. ergonovine administration
resulted in ST segment depression or chest pain
. or both .
Chest pain was relieved by nitroglycerin . and repeat admin-
istration of ergonovine after nitroglycerin produced no or
less prominent ECG changes in 10 patients . No chest pain or
ECG changes were induced in 15 "controls ." Thus, ergono-
vine administration appeared to show promise as a diagnos-
tic agent for coronary artery disease
.
Ergonovine for provocalion of coronary s
pasm. in 1959
Prinzmetal described 32 patients, with angina primarily at
rest, whose ECG showed striking ST segment elevation
during episodes of pain (3) . He hypothesized that these
findings represented severe, transient coronary artery vaso-
constriction, superimposed on atherosclerotic plaque.
"Prinzmetal's" or "variant-" angina gained credibility with
the angfographic demonstration of spontaneous episodes of
coronary artery spasm in patients with rest pain primarily
associated with ST segment elevation (4-6)
. However, such
events were rarely seen during a rteriography
. in
part be-
cause of the common practice of premeditation with nitrates
to avoid catheter-induced spasm of the coronary (especially
right) artery . In 1975, Heupler et al
. (7) reported the use of
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ergonovine maleate to provoke coronary artery spasm dur-
ing artcriucraphy in patients with known or suspected Prinz-
metal' , angina
. Shortly a fterward. i n two large series of
patients who received ergonovine intravenously
(8 .9), the
majority of patients with rest angina associated with ST
segment changes (most commonly ST segment elevation)
had coronary spasm of the "culprit vessel,' in association
with ST segment changes similar to those noted during
spontaneous attacks of angina and precipitation of the pa-
tient's characteristic chest pain
. Conversely . ergonovine
caused minimal, diffuse epicardial coronary oarrowing with-
out ECG changes or chest pain in the majority of patients
who had no ST segment changes during angina or who had
an atypical chest pain syndrome . Even after reports of other
pharmacologic agents or techniques (methacholine . cold
pressor test, hyperventilation, epinephrine, histamine, exer-
cise, for example), ergonovine has remained the reference
standard for provocation of epicardial coronary artery spasm
in patients with Prinzemetal's angina (10).
However, ergonovine has its down side . When it is
administered intravenously. more than one third of patients
experience nausea (and sometimes protracted retching) and
headache, and a substantial minority become marke0y
hypertensive
. Further, if spasm is provoked. all the conse-
quences of spontaneous spasm may be noted in the labora-
tory, including a marked decline in blood pressure and
cardiac output, heart block . ventricular tachycardia and
fibrillation and death (11-13) . The intracoronary administra-
tion of smaller doses of ergonovine (6 to 50 pg in cumlative
doses) may avoid the untoward effects of this agent given
intravenously. but experience with this approach is small
(14).
The present study on intracoronary acetylcholine . In this
issue of the Journal, Okumura and colleagues (15) report that
intracoronary injection of acetylcholine in 70 patients with a
clinical diagnosis of Prinzmetal's angina precipitated severe
coronary constriction with chest pain or ECG changes
(usually ST segment elevation), or both, in 63 . Conversely,
acetylcholine produced lesser degrees of vasoconstriction
without chest pain or ECG changes in all but I of 93 patients
believed on clinical grounds not to have Prinzmetal's angina .
Thus, the sensitivity (90`'/0) and specificity (99
1
/") of acetyl-
choline for induction of coronary spasm in patients with
Prinzmetal's angina rivals large published series of ergono-
vine testing 18,9,13)
. Further, the duration of acetylcholine-
induced spasm was relatively brief even without nitroglyc-
erin, reflecting the short half-life of acetylcholine and . with
the exception of hradycardia (especially after acetylcholine
administration in the right coronary artery). no complica-
lions were encountered . Thus, The investigators propose
intracoronary acetylcholine as a safe and reliable provoca-
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live test for coronary spasm in patients with features of
Prinzmetal's angina but without ECGs obtained during epi-
sodes of chest pain .
These findings and conclusions appear to conflict with the
observations of Ludmer et al. (16) . In that study, intracoro-
nary infusions of acetylcholine over 2 min produced severe
vasoconstriction at the site of left anterior descending coro-
nary artery lesions with transient occlusion in five of eight
patients and angina in four (ECG changes were not re-
ported) . All eight were reported as having a history of effort
angina rather than Prinzmetal's angina . Thus, at least in
patients with coronary artery disease, the specificity of
acetylcholine-induced spasm associated with Prinzmetal's
angina may be substantially lower than Okumura et al . (15)
suggest. Further, in the study of Ludmer CL al . (16), intmco-
ronary acetylcholine caused dilation of most "normal"
coronary arteries, whereas in the study of Okumura et al . .
the coronary arteries in almost 50% of the "control" group
constricted to <50% of the control diameter (which was
normal or near normal in 82% of patients in this group) : only
14% of this group demonstrated vasodilation. In a previous
report from the group of Okumura et al . (17), acetylcholine-
induced coronary vasoconstriction in patients with Prinzme-
tal's angina could be blocked only by atropine, and not by
phentolamine, a finding that argues against a reflex-
sympathetic vasoconstrictor effect. The discrepancies in
coronary artery responses may be due to differences in
acetylcholine administration
. Okumura et al. (15) gave up to
100 pg of acetylcholine over 20 s, whereas Ludmer et al .
gave a somewhat smaller total dose of acetylcholine as a
constant infusion over 2 min .
Role of endothelium-derived relaxant factor. Both groups
refer to the work of Furchgott (18,19) and the observation
that rings of aorta (and subsequently other arteries) denuded
of endothelium constrict in response to acetylcholine, a
response not seen with intact endothelium. Endothelium-
derived relax.m
: factor promotes underlying smooth muscle
relaxation and vasodilation in response to agonists that
would cause smooth muscle contraction and vasoconstric-
tion when in direct contact with smooth muscle (18,19)
.
Thus, intracoronary acetylcholine might have identified re-
gions of the coronary artery with atherosclerotic disease
coexisting with absent or altered endothelium, leaving un-
derlying smooth muscle vulnerable to vasoactive sub-
stances . The different vascular responses to acetylcholine
noted in the studies of Okumura and Ludmer and their
colleagues may relate to an apparent dose-dependent bipha-
sic response of arteries with intact endothelium noted by
Furchgott (19) . At low doses, acetylcholine caused vasore-
taxation
. However, al higher doses (>10
-6
M), acetylcho-
line caused vasoconstriction, perhaps by "overwhelming"
endothelium-derived relaxant factor and stimulating musea-
rinie receptors on underlying smooth muscle
. Curiously,
stimulation of the vago, nerve causes coronary artery dila-
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lion, not constriction, with acetylcholine as the effector
transmitter (20-22) . Indeed, vasorelaxation in response to
parasympathetic nerve stimulation appears to be indepen-
dent of endothelium (22) . Does this finding mean that two
populations of muscarinic receptors exist, some causing
smooth muscle contraction (to intravascular acetylcholine
exposure) and others causing relaxation (to acetylcholine by
way
of neural release)?
Implications
. The relevance of these observations to cur-
onary spasm is unclear Although the denuded endothelium
hypothesis invoked by Okumura, Ludmer and colleagues is
appealing, and probably explains exaggerated coronary va-
somotion in patients with coronary artery disease that may
be clinically relevant (that is, variable angina threshold [23]),
a question remains . Why does a syndrome characterized by
spontaneous severe, focal vasoconstriction occur in a rela-
tively small subset of patients with an ischemic syndrome?
One would think that with the ubiquity of coronary artery
disease in developed societies, Prinzmetal's angina due to
coronary artery spasm would be rampant . Yet in the United
States, it appears to be an uncommon ischemic syndrome .
Clearly, we have much to learn regarding the mechanisms
and clinical significance of coronary artery vasomotion
.
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